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Hereditary xerocytosis is thought to be a rare genetic
condition characterized by red blood cell (RBC)
dehydration with mild hemolysis. RBC dehydration
is linked to reduced Plasmodium infection in vitro;
however, the role of RBC dehydration in protection
against malaria in vivo is unknown. Most cases of
hereditary xerocytosis are associated with gain-of-
function mutations in PIEZO1, a mechanically acti-
vated ion channel. We engineered a mouse model
of hereditary xerocytosis and show that Plasmodium
infection fails to cause experimental cerebral malaria
in thesemice due to the action of Piezo1 in RBCs and
in T cells. Remarkably, we identified a novel human
gain-of-function PIEZO1 allele, E756del, present in
a third of the African population. RBCs from individ-
uals carrying this allele are dehydrated and display
reducedPlasmodium infection in vitro. The existence
of a gain-of-function PIEZO1 at such high fre-
quencies is surprising and suggests an association
with malaria resistance.
INTRODUCTION
PIEZOs are non-selective cation channels that sense mechan-
ical stimuli in many multicellular organisms (Coste et al., 2010;
Ranade et al., 2015). PIEZO1 is essential for mechanotransduc-
tion in vascular development, blood pressure regulation, and
red blood cell (RBC) volume control, among other roles (Liet al., 2014; Ranade et al., 2014b; Retailleau et al., 2015;
Wang et al., 2016; Cahalan et al., 2015). The related PIEZO2
is the principal mechanosensor for touch and proprioception
(Ranade et al., 2014a; Woo et al., 2014, 2015; Chesler et al.,
2016). Human genetic studies have highlighted the significance
of PIEZO1 in human development and physiology. Patients with
loss-of-function mutations in PIEZO1 suffer from persistent
lymphedema caused by congenital lymphatic dysplasia (Lu-
kacs et al., 2015). PIEZO1 mutations are also linked to heredi-
tary xerocytosis, also known as dehydrated hereditary stoma-
tocytosis (Zarychanski et al., 2012; Albuisson et al., 2013; Bae
et al., 2013). Hereditary xerocytosis is a dominantly inherited
blood disorder characterized by RBC dehydration causing
reduced RBC osmotic fragility and is associated with mild or
asymptomatic hemolysis (Delaunay, 2004). This disorder is
considered to be rare and found mostly in the Caucasian pop-
ulation (Archer et al., 2014; Glogowska et al., 2017). Complica-
tions include splenomegaly, resulting from increased RBC trap-
ping in the spleen, as well as iron overload due to unknown
mechanisms (Archer et al., 2014). 19 different point mutations
in PIEZO1 have been described to cause hereditary xerocytosis
(Murthy et al., 2017). Some of these mutations have been elec-
trophysiologically analyzed and show slower inactivation ki-
netics compared to wild-type PIEZO1 channels. The slower
inactivation translates to more ions passing through PIEZO
ion channels, and thus these mutations are considered gain of
function. Consistently, Piezo1 deficiency in RBCs in mice
causes overhydration (Cahalan et al., 2015). Beyond RBCs,
studies in mice have suggested wide-ranging functions of
PIEZO1 in various biological processes; whether hereditary xe-
rocytosis is associated with other conditions beyond RBC pa-
thology is currently not fully understood.Cell 173, 443–455, April 5, 2018 ª 2018 Elsevier Inc. 443
Figure 1. Mouse Model for Human Xerocytosis
(A) Representative traces of mechanically activated (MA) inward currents for wild-type and mPIEZO1 R2482H. ****p < 0.001.
(B) Strategy for generating knockin mouse.
(C) Osmotic fragility test for RBCs.
(D) Quantification for osmotic fragility. Relative tonicity at which 50% RBCs are lysed (half hemolysis) was calculated for each curve. ****p < 0.001.
(E) Scanning electron microcopy images. Heterozygous Piezo1GOF blood RBCs showed signs of stomatocytes.
(F) Splenomegaly in gain-of-function Piezo1 mice (Figure S1C).
Scale bar, 10 mm. Data are presented as means ± SEM. See also Figure S1 and Table S1.Plasmodium, the causative parasite for malaria, has exerted
strong selective pressures on the human genome (Kwiatkowski,
2005). This is demonstrated by severe genetic conditions, such
as sickle cell disease, that persist in human populations fromma-
laria-endemic areas because the underlying genetic variants
confer resistance to Plasmodium infection (Hedrick, 2004;
Feng et al., 2004). The scope of RBC disorders that might
contribute to Plasmodium resistance, however, has not been
fully explored. Interestingly, dehydrated RBCs (including those
from hereditary xerocytosis patients) show delayed infection
rates to Plasmodium in vitro, suggesting a potential protective
mechanism against infections from this parasite (Tiffert et al.,
2005). The effects of dehydrated RBC on Plasmodium infection
in vivo, however, remain unknown. Since overactive PIEZO1
causes dehydrated RBCs in hereditary xerocytosis patients,
we reasoned that mice carrying a gain-of-function Piezo1 allele
could offer a suitable model to investigate the effect of Plasmo-
dium infection in vivo (de Oca et al., 2013).
RESULTS
Piezo1 Gain-of-Function Mice Recapitulate Human
Hereditary Xerocytosis Phenotypes
To test whether gain-of-function Piezo1 expression causes xero-
cytosis-like phenotypes in mice, and to elucidate the role of xe-
rocytosis in Plasmodium infection in vivo, we engineered mice
that conditionally express a human-equivalent hereditary xero-444 Cell 173, 443–455, April 5, 2018cytosis mutation (Figure 1). Specifically, R2456H is a xerocytosis
mutation in human PIEZO1 that displays significantly longer
channel inactivation time (t) (Albuisson et al., 2013). We verified
that the equivalent mouse Piezo1 point mutation (R2482H), when
overexpressed in HEK cells that lack endogenous PIEZO1
(PIEZO1KO HEK) (Dubin et al., 2017), showed slower channel
inactivation (Figure 1A). Since residue 2482 resides in the last
coding exon (51), we designed the knockin construct by flanking
exons 45–51 with loxP sites, followed by a copy of the region
containing exons 45–51 with a mutation that would replace R
with H at residue 2482 (Figure 1B). We named this conditional
allele Piezo1cx. In cells that express Cre recombinase, the wild-
type exon will be replaced by the modified exon, allowing tis-
sue-specific control of gain-of-function Piezo1 expression.
We generated a constitutive gain-of-functionPiezo1mouse line
by crossing mice homozygous for the mutant allele (Piezo1cx/cx)
with cmv-cre mice that expressed a Cre driver ubiquitously
(Schwenk et al., 1995). We also generated a hematopoietic line-
age-specific gain-of-functionPiezo1mouse line (Piezo1GOF blood)
using vav1-cre (deBoer et al., 2003). Toevaluate the expressionof
the gain-of-function allele, we sequenced the last exon of Piezo1
cDNA from whole blood of homozygous Piezo1GOF blood
and observed the expected nucleotide change c.GG7742-7743AC
(Figure S1A). In addition, we found that Piezo1 transcript levels
in whole blood from both homozygous and heterozygous
Piezo1GOF blood mice were similar to levels observed in wild-
type mice, demonstrating that the genetic manipulation did not
Figure 2. Plasmodium Infection in Gain-of-
Function Piezo1 Mice
(A) Survival curves for gain-of-function Piezo1mice
after P. berghei infected RBCs.
(B and C) Parasitemia recorded by flow cytometry
for phase 1 (first 7 days, B) and phase 1 and 2
together (24 days, C), respectively.
(D) Intact blood-brain barrier in infected gain-of-
function Piezo1 mice.
(E) Quantification of blood-brain barrier disruption.
(F) Brain water content in infected brains.
*p < 0.05, **p < 0.01, and ***p < 0.001. Scale bar,
5 mm. Data are presented as means ± SEM.alter Piezo1 expression levels (Figure S1B). We also found that
both constitutive (Piezo1GOF constitutive) and blood-cell-specific
(Piezo1GOF blood) transgenic mice (heterozygous and homozy-
gous) were born at the expected Mendelian ratio and appeared
to develop normally.
We found that RBCs fromboth homozygous and heterozygous
Piezo1GOF blood mice showed reduced osmotic fragility, as
shown by a left-shifted curve in a hypotonicity-dependent hemo-
lysis challenge (Figures1Cand1D). Thisdemonstrates thatRBCs
from gain-of-function Piezo1 mice are more resistant to lysis
in response to hypotonic solutions compared to wild-type, a
defining feature for hereditary xerocytosis (Archer et al., 2014).
Piezo1GOF blood mice also displayed hematological properties
similar to mild anemia, indicated by a lower hemoglobin level
and increased reticulocyte number, as is the case for individuals
with hereditary xerocytosis (Table S1). Those patients also have
increased mean corpuscular volume, which is a measure of
RBC volume, and increased mean corpuscular hemoglobin,
which indicates averagehemoglobinmassperRBC (Zarychanski
et al., 2012; Albuisson et al., 2013; Bae et al., 2013; Archer et al.,
2014).We found that shifts in these two values in gain-of-function
Piezo1mice were similar to those observed in hereditary xerocy-
tosis patients.Meancell hemoglobin concentration, in contrast—
which is expected to be elevated in dehydrated RBCs—was not
significantly increased in homozygous Piezo1GOF blood mice.
Importantly, however, we found that RBCs from these mice
were nevertheless dehydrated, as they showed reduced osmoticfragility (Figures 1C and 1D). In addition,
we used scanning electron microscopy
and found the presence of RBCs with
deformed and dehydrated shapes from
heterozygous Piezo1GOF blood mice,
which is another clinical feature often
observed in patients (Figure 1E). One of
the predominant features of hereditary xe-
rocytosis is splenomegaly. We found that
both homozygous and heterozygous
Piezo1GOF blood mice had significantly
larger spleens (1.04 ± 0.03, 0.74 ±
0.02 cm2, respectively) compared to
wild-types (0.42 ± 0.02 cm2, n = 4 animals
per genotype, Student’s t test, compared
to wild-type, p < 1 3 104) (Figures 1F
and S1C). Together, our data show thatgain-of-function Piezo1 mice display hallmark clinical features
observed in human hereditary xerocytosis patients, including
RBC dehydration, mild anemia, and splenomegaly.
Gain-of-Function Piezo1 Mice Have Reduced Growth
Rate of Plasmodium Blood Stages and Protect against
Experimental Cerebral Malaria
To evaluate the connection between Piezo1, RBC dehydration,
and protection against malaria, we infected gain-of-function
Piezo1 mice with a GFP-expressing reference line of the ANKA
strain of rodent malaria parasite Plasmodium berghei (Franke-
Fayard et al., 2004). We chose P. berghei ANKA since this para-
site is a well-established model to analyze the course of infec-
tions in vivo, and to investigate experimental cerebral malaria
in mice (Franke-Fayard et al., 2004; de Souza et al., 2010; Hunt
et al., 2010). We found that wild-type mice died between day 6
and 8, consistent with previous findings (Franke-Fayard et al.,
2004; de Oca et al., 2013) (Figure 2A). In contrast, we observed
that the homozygous and heterozygous Piezo1GOF constitutive
mice survived as long as 24 and 19 days, respectively (Figure 2A).
Importantly, the post-infection survival rates of Piezo1GOF blood
mice were indistinguishable from Piezo1GOF constitutive
mice, indicating that induction of gain-of-function Piezo1 in
hematopoietic lineages was sufficient to extend post-infection
survival (Figure 2A).
Next, we analyzed the course of infection in wild-type and
gain-of-function Piezo1 mice to test whether the expression ofCell 173, 443–455, April 5, 2018 445
the mutant Piezo1 allele affects Plasmodium growth rate in
RBCs, as suggested by previous in vitro experiments (Tiffert
et al., 2005). We measured the percentage of RBCs that were
GFP positive (parasitemia) by flow cytometry. During the first
week of infection (phase 1, Figure 2B), we found that parasitemia
reached 6%–12% in wild-type mice at the time of death; how-
ever, both Piezo1GOF constitutive and Piezo1GOF blood mice had
significantly lower parasitemia (on day 6, 5.14% ± 0.42% for
constitutive mice and 5.20% ± 0.34% for blood-cell-specific
mice, p < 0.05 compared to wild-type, 8.53% ± 1.65%, Stu-
dent’s t test). These findings suggest that expression of a gain-
of-function Piezo1 allele in blood cells reduce parasite growth
rate of blood stages (Figure 2B). Unlike wild-type animals, which
all died at the end of phase 1, gain-of-function Piezo1mice then
entered a second phase of infection (phase 2; day 7 to day 23,
Figure 2C). We found that during this phase, they exhibited a
steady increase in parasitemia, eventually leading to severe hy-
perparasitemia of up to 70% of infected RBCs (Figures 2B and
2C). These data suggest that gain-of-function Piezo1 expression
can dramatically modify the course of Plasmodium infection
in vivo, leading to enhanced survival, despite high end-stage
levels of parasitemia (Figure 2C).
A prominent feature of experimental cerebral malaria in the
P. berghei ANKA/C57BL/6 infection model is the breakdown
of blood-brain barrier (Nacer et al., 2014). We injected Evans
blue dye intomice and studied blood-brain barrier compromise.
As expected, we observed blue dye leakage into brain paren-
chyma in all wild-type mice at day 6 after infection (n = 8) (Fig-
ure 2D, left), indicating blood-brain barrier breakdown. Remark-
ably, we did not detect Evans blue leakage in the brains of
Piezo1GOF blood (n = 7) even at day 18 when they were about
to die (Figure 2D, right). To quantitatively evaluate blood-brain
barrier disruption, we measured the optical density of Evans
blue dyes extracted from infected brains (n = 5 per genotype)
(Ferreira et al., 2011). We observed a significant reduction in
brain Evans blue contents in infected Piezo1GOF blood
compared to wild-type mice (Figure 2E). In addition, we evalu-
ated experimental cerebral malaria by measuring brain water
content that reflects the severity of brain edema caused by ce-
rebral complications (Hunt et al., 2014). Wild-type mice had
increased brain water content after infection compared to
Piezo1GOF blood mice (Figure 2F). Thus, our data show that
gain-of-function Piezo1-expressing mice are protected against
experimental cerebral malaria. However, these mice eventually
died, probably due to severe anemia, as they showed reduced
hemoglobin (HGB) levels (2.85 ± 2.5 g/dL, n = 3, in Piezo1GOF
blood mice 18 days after infection) compared to uninfected
Piezo1GOF blood mice (14.02 ± 0.16 g/dL, n = 5, p < 0.002) (Phil-
lips and Pasvol, 1992). Together, our results suggest that gain-
of-function Piezo1 expression reducesPlasmodium growth rate
of blood-stage infection in vivo and can protect mice from the
development of cerebral complications. The reduced Plasmo-
dium infection rate of dehydrated RBCs observed in vitro (Tiffert
et al., 2005) can explain the reduced parasite growth rate of
blood stage observed in gain-of-function Piezo1 mice during
phase 1; however, a connection between dehydrated RBCs
and protection from experimental cerebral malaria was novel
and unexpected.446 Cell 173, 443–455, April 5, 2018RBC Dehydration Is Responsible for Reduced Parasite
Growth and Partially Responsible for Protection against
Cerebral Malaria in Gain-of-Function Piezo1 Mice
To address whether decreased parasite growth rate and preven-
tion of experimental cerebral malaria in the gain-of-function
Piezo1 mice were due to RBC dehydration, we genetically
rescued RBC dehydration in gain-of-function Piezo1 mice and
assessed P. berghei infection. We took advantage of the
fact that PIEZO1-induced RBC dehydration requires the activity
of KCa3.1, a calcium-dependent potassium channel (also known
as Gardos channel). Activation of KCa3.1 drives potassium and
water out of RBCs in response to increased intracellular calcium,
thereby causing dehydration (Maher and Kuchel, 2003; Cahalan
et al., 2015). We crossed the gain-of-function Piezo1 mice to
KCa3.1 knockout mice. As expected, Piezo1GOF blood/
KCa3.1/ mice had osmotic fragility similar to wild-type
mice, demonstrating that RBC dehydration was corrected by
removing KCa3.1 channel activity (Figures 3A and S2). After
P. berghei ANKA infection, Piezo1GOF blood/KCa3.1/ mice
survived significantly longer than wild-type (but shorter than
Piezo1GOF blood). This resulted in an intermediate survival curve
of Piezo1GOF blood/KCa3.1/ mice (p < 0.0001, compared to
wild-type and Piezo1GOF blood) (Figure 3B). This suggests that
correction of RBC dehydration fails to reverse survival rate to a
level that is similar to wild-type, indicating that RBC dehydration
is not completely responsible for the increased survival rate in
the gain-of-function Piezo1 mice.
We also found that Piezo1GOF blood/KCa3.1/ mice had a
parasite growth rate of blood stage that was indistinguishable
from that ofwild-type during the first week of infection, suggesting
that RBC dehydration was responsible for the reduced parasite
growth observed during phase 1 in gain-of-function Piezo1 mice
(Figure 3C). Importantly, KCa3.1 knockout mice in wild-type
Piezo1 background did not show changes in parasitemia, sug-
gesting that the absence of KCa3.1 per se did not influence
RBC infection (Figure 3C, gray). Finally, quantitative measure-
ments of both Evans blue and brain water content in infected
brainsshowed thatPiezo1GOFblood/KCa3.1/miceexperienced
an intermediate level of cerebral complications betweenwild-type
and Piezo1GOF blood mice (Figures 3D–3F). Together, our data
from Piezo1GOF blood/KCa3.1/ genetic experiments suggest
that (1)RBCdehydration iscompletely responsible for the reduced
parasite growth rate (phase 1); and (2) RBC dehydration is amajor
contributing factor for the absence of experimental cerebral ma-
laria (phase 2), but that other mechanisms may be involved.
Gain-of-Function Piezo1 Expression in RBCs and T Cells
Contributes to Protection against Cerebral Malaria
The incomplete protection from experimental cerebral malaria
in Piezo1GOF blood/KCa3.1/ mice (despite normal parasite
growth rate) suggests the existence of other mechanisms that
affect cerebral complication in gain-of-function Piezo1 mice.
Previous work has shown that processes critical for the develop-
ment of cerebral malaria in both humans and rodents involve
both RBCs and immune cells (Baptista et al., 2010; Nacer
et al., 2014; Dunst et al., 2017). To directly address the cell
autonomous function of gain-of-function Piezo1 allele in these
cells, we induced expression of gain-of-functionPiezo1mutation
Figure 3. Role of RBC Dehydration in Plas-
modium Infection in Mice
(A) Deletion of KCa3.1 in heterozygous
Piezo1GOF blood mice (orange) restored RBC
dehydration in heterozygous Piezo1GOF blood
(green). Piezo1GOF blood/KCa3.1/ mice had a
similar curve to wild-type.
(B) Post infection survival rate of Piezo1GOF blood/
KCa3.1/ mice (orange) is intermediate
between wild-type (black) and heterozygous
Piezo1GOF blood mice (green). p < 0.0001, Mantel-
Cox tests.
(C) Both Piezo1GOF blood/KCa3.1/ and
KCa3.1/ mice had same parasitemia as wild-
type, with significantly higher than heterozygous
Piezo1GOF blood mice.
(D) Breakdown of blood-brain barrier in
Piezo1GOF blood/KCa3.1/ mice 13 days after
infection.
(E) Quantification for blood-brain barrier disruption.
(F) Brain water content in infected brains.
*p < 0.05, **p < 0.01, and ***p < 0.001. Scale bar,
5 mm. Data are presented as means ± SEM. See
also Figure S2.in different blood cell types and tested survival rate, parasite
growth rate, and experimental cerebral malaria.
First, we generated RBC-specific gain-of-function Piezo1
mice (Piezo1GOF RBC) with EpoR-cre (Heinrich et al., 2004).
We verified the efficiency and specificity of EpoR-cre expression
bymeasuring RBC osmotic fragility for Piezo1GOF RBCmice. We
found that these mice had reduced RBC fragility, similar to
Piezo1GOF blood mice, suggesting that EpoR-cre was efficiently
inducing recombinase activity in most RBCs (Figures 4A and
S3A). Also, gain-of-function Piezo1 mRNA was not present in
immune cells (CD4+ and CD8+ T cells) from Piezo1GOF RBC
mice. This is an important control, as we address the role of
gain-of-function Piezo1 expression in T cells separately (see
below) (Figure S4B). We found that infection of Piezo1GOF RBC
micewithP. berghei caused a survival rate indistinguishable from
Piezo1GOF blood mice (Figure 4B). Furthermore, Piezo1GOF RBC
mice had a parasitemia curve indistinguishable from
Piezo1GOF blood mice and did not develop experimental cerebral
malaria (Figures 4C and 4D). These data suggest that the expres-
sion of gain-of-function Piezo1 in RBCs is sufficient to cause
reduced Plasmodium growth rates and to protect mice from
the development of cerebral complications.
Parasite-specific CD8+ cells are essential in causing Plasmo-
dium-inducedcerebral complications (Yan˜ezet al., 1996;Belnoue
et al., 2002; Howland et al., 2015). We induced gain-of-functionPiezo1 expression in peripheral CD4+ and
CD8+ T cells by using hCD2-cre (Vacchio
et al., 2014). We tested the specificity
of hCD2-cre by measuring RBC osmotic
fragility and showed that Piezo1cx/+;
hCD2-cre (Piezo1GOF T cells) mice had
normal RBC fragility, confirming that
hCD2-cre did not induce gain-of-function
Piezo1 expression in RBCs (Figures 4Aand S3A). Furthermore, we evaluated the efficiency of hCD2-cre
in targeting CD4+ and CD8+ T cells by sequencing the cDNA
made by those cells from homozygous Piezo1GOF T cells mice
and found that gain-of-functionPiezo1mRNAwas theonlyPiezo1
transcript expressed in the targeted cells (Figure S3B).
We found that, after P. berghei infection, Piezo1GOF T cells
mice survived significantly longer than wild-type mice (p <
0.01), but not as long as Piezo1GOF blood or Piezo1GOF RBC
mice (p < 0.01), suggesting that expression of gain-of-function
Piezo1 in T cells provided partial protection (Figure 4B). Further-
more, we found that parasitemia in Piezo1GOF T cells mice was
identical to that of wild-type mice during the first 7 days after
infection, before it continued climbing until the end of the infec-
tion (Figure 4C, compare dark blue and black). This suggested
that gain-of-function Piezo1 expression in CD4/8+ T cells did
not alter parasite growth rate of blood stage compared to wild-
type mice (phase 1). Intriguingly, despite wild-type-like parasite
growth rates during the first 7 days, Piezo1GOF T cells mice
displayed attenuated experimental cerebral malaria during
phase 2 (Figures 4D and 4E). Also, Piezo1GOF T cells mice had
an intermediate level of cerebral complications between wild-
type and Piezo1GOF RBC mice (Figure 4F). These data demon-
strate that gain-of-function Piezo1 expression in T cells can pro-
vide partial survival advantage by attenuating the disruption of
the blood-brain barrier seen in experimental cerebral malaria.Cell 173, 443–455, April 5, 2018 447
Figure 4. Role of Gain-of-Function Piezo1 Expression in RBCs and T Cells during Plasmodium Infection in Mice
(A) RBC osmotic fragility for different gain-of-function Piezo1 mice.
(B) Mice with gain-of-function Piezo1 in different blood cells had distinct survival rates after infection. Piezo1GOF RBC (red) had survival rate similar to pan-blood-
cell-specific mice (Piezo1GOF blood [green]), p > 0.05. Macrophage-specific gain-of-function mice (Piezo1GOF macrophage) had same survival rate as wild-type,
p > 0.05. Piezo1GOF T cells had a survival rate greater than wild-type (p < 0.01) and less than Piezo1GOF blood mice (p < 0.01). Mantel-Cox tests.
(C) Parasitemia recorded by flow-cytometry for gain-of-function mice. *p < 0.05, **p < 0.01, and ***p < 0.001, Student’s t test.
(D) Blood-brain barrier compromise in T cell- and RBC-specific gain-of-function mice after infection.
(E) Quantification for blood-brain barrier disruption.
(F) Brain water content in infected brains.
Scale bar, 5 mm. Data are presented as means ± SEM. See also Figure S3.Finally, we tested whether gain-of-function Piezo1 expression
in macrophages can affect Plasmodium infection, since macro-
phages have been shown to be important for both protection
and pathology in malaria (Chua et al., 2013). We expressed448 Cell 173, 443–455, April 5, 2018gain-of-function Piezo1 specifically in macrophages using
LysM-cre (Clausen et al., 1999). Piezo1GOF macrophage mice dis-
played survival rate (Figure 4B) and parasitemia curves similar to
wild-type littermates (Figure 4C). These results indicate that
Figure 5. Identification of Gain-of-Function PIEZO1 Mutations in African Populations
(A and B) Yoda1-induced intracellular calcium signals in PIEZO1KO HEK cells overexpressing A1988V (A) and E756del (B) cDNA (*p < 0.05). Allele frequency for
both mutations is shown in the insets.
(C) Representative traces of mechanically activated (MA) inward currents for wild-type and mutated cDNA. R2456H, A1988V, and E756del mutations.
(D) Quantification for inactivation time (t).
each point = a single cell. ***p < 0.001, **p < 0.01. Data are presented as means ± SEM. See also Table S2.macrophages are unlikely to play an essential role in reducing
parasite growth rate and protection against experimental cere-
bral malaria in xerocytosis mice. Together, our data suggest
that RBCs play a major role in gain-of-function Piezo1-mediated
protection against Plasmodium infection and cerebral malaria;
however, T cells also appear to be involved in protection against
cerebral complications.
Identification of a Common Human PIEZO1 Gain-of-
Function Mutation in African Populations under Positive
Selection
The role of gain-of-function PIEZO1 in rodent malaria described
here raises a conundrum: if PIEZO1 mutations are protective
againstPlasmodium infection, why then is hereditary xerocytosis
not commonly observed in individuals from Africa, where malaria
is highly prevalent? To investigate whether common PIEZO1
gain-of-function mutations are present in African populations,
we took a comparative genomics approach to look for possiblePIEZO1 gain-of-function alleles and cataloged nonsynonymous
(missense) SNPs and in-frame insertions/deletions (indels) in
PIEZO1. To maximize the likelihood of finding gain-of-function
mutations, we (1) performed our search using the Exome Aggre-
gation Consortium data (ExAC) (Lek et al., 2016); (2) picked
PIEZO1 SNPs or indels with allele frequencies above 0.5%;
and (3) picked mutations that were more than 5-fold enriched
in African populations, as compared to people of non-African
descent. Using these criteria, we found 21 mutations consisting
of 19 SNPs and 2 indels (Table S2).
To test for potential functional effects of the various mutations,
we next performed a large-scale calcium-imaging assay by
screening the 21 candidate mutations for increased response
to various concentrations of the PIEZO1 agonist Yoda1 (Syeda
et al., 2015). We found that two of the 21 mutations lead to
increased PIEZO1 responses in this screen: amino acid substitu-
tion A1988V (SNP) and indel E756del (3 nucleotide deletion) (Fig-
ures 5A and 5B). We found that the A1988Vmutation only has anCell 173, 443–455, April 5, 2018 449
allelic frequency of 0.8% in the African population (inset in
Figure 5A). In contrast, the E756del mutation has an allelic fre-
quency of 18% in individuals of African descent (3% in Euro-
peans), and therefore present in at least 1 copy in about a third
of African population (inset in Figure 5B).
To test whether these mutations lead to gain-of-function
PIEZO1 channel kinetics, we recorded mechanically activated
currents and found that PIEZO1 variants containing A1988V or
E756del mutations was activated normally by mechanical force
but had significantly longer inactivation time constants (t)
compared to wild-type (p < 0.0001). This is similar to R2456H, a
gain-of-function allele that has the longest inactivation time
among all hereditary xerocytosis mutations (Albuisson et al.,
2013) (Figures 5C and 5D), and the equivalent of this allele was
used to create our gain-of-function Piezo1mice (Figure 1). These
data show that gain-of-functionPIEZO1mutationswith similar ion
channel activities to those causing hereditary xerocytosis in
Caucasian families (Albuisson et al., 2013) can be found in
individuals of African descent. At least one of these, E756del, is
present in one-third of African individuals, suggesting a potential
connectionbetweenPIEZO1,hereditaryxerocytosis, andmalaria.
We focused on the more abundant allele, E756del. We hypoth-
esized that this allele may be under positive selection in African
populations, where malaria is endemic. To test this hypothesis,
we assessed threemain signatures of selection, commonly found
in allelic variants under positive selection (Sabeti et al., 2006): (1)
population differentiation of the allele observed between African
and non-African populations, as measured by Fst; (2) whether a
variant is in linkage-disequilibrium with nearby SNPs creating a
long-range haplotype block, which is commonly observed in
more recent (<25,000 years) selective sweeps; and (3) whether
the allele is derived (i.e., non-ancestral), since such new alleles
typically have lowpopulation frequencies, unless under selection.
We looked at the frequency of the E756del allele in the popu-
lations present in the 1000 Genomes catalog (Auton et al., 2015)
and found that it is present at high allelic frequency (9%–23%) in
all populations of African descent, including African Americans
(allelic frequency 14%), but not in individuals of non-African
ancestry (allelic frequency <1%, Figure 6A). The observed geno-
type frequencies at this locus are in Hardy-Weinberg equilibrium
(c2 = 0.201, p = 0.654), and therefore segregating as expected in
a randomly mating population. Next, we investigated population
differentiation across the 1000 Genomes populations. We calcu-
lated FST values at all PIEZO1 missense mutation loci between
individuals of African and non-African descent and found that
the populations were most differentiated using the E756del
allele (FST for E756del = 0.32, FST of all other PIEZO1 missense
alleles = 0–0.26, Figure 6B). This finding is consistent with
E756del being under positive selection in populations where
malaria is endemic.
We next investigated the regions surrounding the E756del
locus but did not observe any SNPs in significant linkage
disequilibrium with E756del. The lack of an observed long haplo-
type flanking this allele makes it harder to conclusively provide
proof of positive selection of the E756del variant (Vitti et al.,
2013). The lack of linkage disequilibrium, however, could also
be because this allele might have been subject to selection on
standing variation (i.e., not as the result of a selective sweep450 Cell 173, 443–455, April 5, 2018[Sabeti et al., 2006]), or because the selective pressure on this
locus is relatively old (>25,000 years). Even though Plasmodium
is an ancient parasite (Loy et al., 2017), the former is still a likely
explanation because the expansion of P. falciparum and subse-
quent impacts on human selection likely began in the last 10,000
years (Joy et al., 2003).
To assess whether the E756del variant is derived (i.e., is a new
allele that occurred in Africans) or ancestral, we investigated the
architecture of the PIEZO1 locus in the archaic humans and non-
human primates. There is low amino acid sequence homology
near the E756del locus between humans and non-human pri-
mates (Figure S4A); thus, we could not investigate pre-human
ancestry. We found, however, that both Neanderthals and
Denisovans had the wild-type E756 in their PIEZO1 genes
(Figures 6C and S4B). This finding shows that the PIEZO1
E756del gain-of-function allele is derived in individuals of African
descent, again consistent with being under positive selection
(Sabeti et al., 2006). Combined, our analyses show that the
PIEZO1 gain-of-function mutation E756del is a high-frequency
(present in one-third of African population) derived allele that is
highly differentiated in populations where malaria is endemic.
These findings are highly suggestive of the E756del genetic
variant being under positive selection in populations of African
descent (Sabeti et al., 2006), presumably because of its likely
role as a malaria-protective allele.
RBCs from E756del African American Carriers Are
Dehydrated and Cause Reduced Infection by
Plasmodium falciparum In Vitro
We acquired blood samples from healthy volunteer African
American donors and tested whether E756del causes xerocyto-
sis-like RBC dehydration and, importantly, whether it confers
attenuation of infection against P. falciparum in vitro. We ob-
tained 25 whole-blood samples and used white blood cells to
sequence the exon containing E756del. We found that nine
(36%) African American donors were heterozygous for E756del
(none were homozygous) (Figure S5A). We also screened all 25
donors for other known common mutations that affect RBC
morphology and could potentially influence susceptibility to
Plasmodium infection. Our sequencing results showed that all
25 donors were free of HbS, HbC, and HbE mutations in the
b-globin chains that cause hemoglobinopathy (Figure S5B). In
addition, we showed that none of the 25 donors had the varia-
tions that cause a-thalassemia (Figure S5C), another condition
associated with RBC abnormality and Plasmodium infection
(Chong et al., 2000).
Next, we imaged RBCs with scanning electron microscopy
from three carriers and showed that all had RBCs with echino-
cyte and stomatocyte morphologies, which is a characteristic
of hereditary xerocytosis RBCs (Figure 7A). Remarkably, we
also found that RBCs from all 9 donors with the E756del mutation
were dehydrated as assayed by osmotic fragility test (Figures 7B
and 7C), similar to RBCs from known xerocytosis patients
(Delaunay, 2004; Archer et al., 2014). Next, we infected both
control and E756del carrier RBCs with P. falciparum in vitro.
Parasitemia was significantly lower for E756del carriers relative
to non-carriers, measured by both Giemsa and SYBR green
staining methods (Figures 7D and 7E) (Johnson et al., 2007).
Figure 6. Population Genetics of PIEZO1 Gain-of-Function E756del Allele Common in Populations of African Descent
(A) Human population demographics for E756 indels. E756 deletion (TCC/–) exists at high frequencies in all populations of African descents (purple). A minor
allele, E756 insertion (TCC/TCCTCC) was also discovered (coral).
(B) Differentiation (FST) between populations of African and non-African ancestry at each loci for all PIEZO1 missense mutations. Alleles are colored by whether
the minor allele frequency (MAF) was highest in African (red) or non-African (black) populations, or were similar (gray).
(C) A nucleotide alignment of modern and pre-modern (Neanderthal and Denisovan) human PIEZO1minus strand sequences around the E756del allele showing
the codon positions. (Ambiguous base: M = C or A; R = A or G). The TCC deletion (GGA on minus strand) spans two codons but only deletes E756 while shifting
nucleotides to leave D757 intact. Individual Neanderthal and Denisovan reads used to create this alignment and comparisons to non-human primate PIEZO1
amino acid sequences are shown in Figure S4.
See also Figure S4.Together, our data demonstrate that E756del is a common
PIEZO1 gain-of-function mutation in African populations,
causing RBC dehydration in otherwise healthy African Ameri-
cans, and is likely under positive selection, due to its ability to
confer reduced susceptibility of RBCs to P. falciparum infection.
DISCUSSION
Gain-of-Function Piezo1 Expression in Blood Cells
Provides Protection against Plasmodium-Induced
Cerebral Complications In Vivo
Dehydrated RBCs, including those from hereditary xerocytosis
patients, show slower infection rates to P. falciparum in vitro (Tif-
fert et al., 2005). However, this mechanism of protection has
never been tested in vivo. To address these issues, we engi-
neered a gain-of-function Piezo1 mouse that recapitulated
most features of hereditary xerocytosis. Remarkably, gain-of-function Piezo1mutation induced in different types of blood cells
caused dramatic shifts in survival rates in response to P. berghei
infection, caused by reduced parasite growth rate of blood stage
as well as protection from experimental cerebral malaria.
Our mouse genetic data suggest that gain-of-function
Piezo1-induced RBC dehydration is a major determinant in
the protection against cerebral complications of malaria.
Several other genetic mutations that affect RBC morphology
are associated with resistance to malaria in human populations
(Hedrick, 2004; Feng et al., 2004), and some of these mutations
also cause RBC dehydration, such as sickle cell disease
(Brugnara, 1995). Similar experiments can be performed in
the future to evaluate the potential contribution of RBC dehy-
dration to malaria resistance in the genetic disorders mentioned
above. Another important next step is to determine the molec-
ular mechanisms responsible for RBC-dehydration-dependent
attenuation of Plasmodium infection.Cell 173, 443–455, April 5, 2018 451
Figure 7. Characterization of RBCs from E756del Carriers for Xerocytosis-like Phenotypes and P. falciparum Infection
(A) SEM images. Three individual E756del carriers have RBCs with echinocytes (white arrowhead) and stomatocytes (yellow arrowhead), magnified in lower
panels. Scale bar for upper panels, 10 mm; for lower panels, 5 mm.
(B and C) Osmotic fragility test. RBCs from E756del heterozygous carriers (n = 9) had a left-shifted curve (blue) compared to controls (n = 16) (black) (B), as
quantified in (C) **p < 0.01.
(D and E) P. falciparum infection into RBCs from E756del carriers. Giemsa staining (D) and SYBR Green labeling of parasite DNA inside RBCs (E) (**p < 0.01,
*p < 0.05).
Statistics: Student’s t test for each time point. Data are presented as means ± SEM. See also Figure S5.
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In addition to RBC dehydration, we discovered an unexpected
function of gain-of-function PIEZO1 in immune cells during
Plasmodium infection. T cells play both pathogenic and protec-
tive roles in human malaria, as well as in murine malaria models
(Hafalla et al., 2006; Ewer et al., 2013). T cells experience diverse
mechanical stimuli during development and function, but the role
of mechanosensitive ion channels in immune cells is poorly un-
derstood (Huse, 2017). It is possible that overactive PIEZO1
channels alter T cell developmental programs and/or modulate
their activity when encountering parasites. It will be of interest
to use both gain-of-function and loss-of-function Piezo1 mice
to explore the role of this ion channel in T cells.
The Discovery of Gain-of-Function PIEZO1 Allele
Present in One-Third of the African Population
The discovery of gain-of-function PIEZO1 E756del in African
populations with a high allele frequency of 18% (such that an
estimated one-third of African people carry this mutation as
heterozygotes) is quite surprising. Our findings dramatically
redefine the epidemiology of this disorder: hereditary xerocyto-
sis-like condition is much more common than previously antici-
pated. Thus, E756del provides a unique opportunity to evaluate
the association between gain-of-function PIEZO1, RBC dehy-
dration, and malaria in endemic regions.
Despite the experimental evidence above, PIEZO1 locus was
not detected as a strong candidate by recent genome-wide as-
sociation studies (GWASs) that aimed to identify genetic loci for
severe malaria resistance (Leffler et al., 2017). This is potentially
due to GWAS limitations and the complexity of this particular
genetic locus. GWAS samples have high levels of genetic diver-
sity and are underrepresented in reference panels of genetic
variation (Malaria Genomic Epidemiology Network, 2014; Leffler
et al., 2017). Also, GWASs mainly use SNPs to determine asso-
ciation, and this would be challenging to evaluate more complex
loci without genetic imputation method. E756del is in such a
locus with multiple short tandem repeats (Figure 6C), so that
imputation of this mutation into current GWAS datasets is not
straightforward. In this regard, our experimental data provide
promising clues for association analysis: sequencing this partic-
ular locus in endemic population can determinewhether E756del
is associated with protection against severe malaria.
E756del Provides an Opportunity to Evaluate the Role of
Overactive Mechanotransduction in Human Health
Does E756del allele cause hereditary xerocytosis and other dis-
orders? We readily identified E756del carriers from self-reported
healthy African American blood donors. Whether E756del car-
riers have anemia or splenomegaly is not known to date. A full
clinical evaluation of individuals carrying this allele will be of
high interest to assess how overactive PIEZO1 influences xero-
cytosis-related phenotypes, as well as other conditions. For
example, analysis of loss-of-function Piezo1 mice has demon-
strated a critical role of this ion channel in cardiovascular func-
tion (Retailleau et al., 2015; Wang et al., 2016; Rode et al.,
2017). Therefore, it will be of interest to assess the role of over-
active PIEZO1 channel in hypertension, which has high inci-
dence in African Americans (Kaplan, 1994). We expect that
a complete clinical characterization of individuals with theE756del allele will shed further light on the range of phenotypes
that are associated with PIEZO1, including anemia, splenomeg-
aly, autoimmune diseases, various aspects of cardiovascular
function, as well as in indications not previously associated
with PIEZO1.
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259cl2
California Institute for Biomedical Research, La
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hsp70-Luc-eef1a
Leiden Malaria Research Group, the Netherlands line 1868
Plasmodium falciparum Elizabeth Winzeler, university of California,
San Diego
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CTCACAGACAGGTGTTCATC This paper RT-PCR for mouse Piezo1 mRNA
GCAAACTCACGTCAAGGAGA This paper RT-PCR for mouse Piezo1 mRNA
GCACCACCAACTGCTTAG This paper RT-PCR for mouse gapdh mRNA
GGATGCAGGGATGATGTTC This paper RT-PCR for mouse gapdh mRNA
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AGCCCACGTTGTGTTCATGGC Chong et al., 2000 a-thalassemia SEA-R
(Continued on next page)
e1 Cell 173, 443–455.e1–e6, April 5, 2018
Continued
REAGENT or RESOURCE SOURCE IDENTIFIER
TGCAAATATGTTTCTCTCATTCTGTG Chong et al., 2000 a-thalassemia FIL-F
ATAACCTTTATCTGCCACATGTAGC Chong et al., 2000 a-thalassemia FIL-R
GCCCAACATCCGGAGTACATG Chong et al., 2000 a-thalassemia 20.5-F
TACCCTTTGCAAGCACACGTAC Chong et al., 2000 a-thalassemia MED-F
TCAATCTCCGACAGCTCCGAC Chong et al., 2000 a-thalassemia MED-R
Recombinant DNA
Plasmid: 3.2pc-IRES-tdTomato This paper N/A
Software and Algorithms
Prism7 GraphPad software https://www.graphpad.com
Geneious Geneious https://www.geneious.com/CONTACT FOR REAGENT AND RESOURCE SHARING
Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Ardem
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EXPERIMENTAL MODEL AND SUBJECT DETAILS
All animal procedures were approved by the Institutional Animal Care and Use Committees of The Scripps Research Institute (TSRI).
Mice
Piezo1GOF blood, Piezo1GOF constitutive, Piezo1GOF T cells, Piezo1GOF macrophage, and Piezo1GOF RBC mice were generated by
breeding Piezo1cx/cx with vav1-cre (The Jackson Laboratory, stock# 018968) and cmv-cre (The Jackson Laboratory stock#
006054), hCD2-cre (The Jackson Laboratory stock# 027406), LysM-cre (The Jackson Laboratory stock# 004781), and EpoR-cre
(a gift from Dr. Klingmuller group at Max-Planck-Institute fu¨r Immunbiologie, Freiburg, Germany). KCa3.1 / mice were ordered
from The Jackson Laboratory (stock# 018826). Gain-of-function Piezo1 mice were generated and maintained on C57BL/6 back-
ground. All animals were backcrossed at least 10 generations to C57BL/6. The mice were housed in a 12hr light/dark cycle (light
from 6am to 6pm) in a temperature-controlled room (24 degree) with free access to food and water. The ages and sexes of mice
are indicated in the following method section. Littermates were used for experiments.
Cell lines and cell culture
PIEZO1KO HEK cells were grown in Dulbecco’s modified Eagle’s medium containing 4.5 mg/ml glucose, 10% fetal bovine serum,
1 3 antibiotics/antimycotics.
Human blood samples
The collection of human whole blood was approved by TSRI normal blood donor service. Fresh whole blood from TSRI normal blood
donor service was drawn and kept at ambient temperature (in heparin-coated containers), followed by osmotic fragility test and P.
falciparum infection experiments (see below) on the same day. Whole blood from Biological Specialty Corporation was delivered by
air at ambient temperature the next day after collection for further experiments.
METHOD DETAILS
P. berghei infections and parasitemia measurement by flow cytometry
Donor mice (C57BL/6) were intraperitoneally injected with 50-200 mL of erythrocytes parasitized with either P. berghei (ANKA)
GFPcon 259cl2 (provided by California Institute for Biomedical Research, La Jolla, USA) or P. berghei (ANKA) mCherry-hsp70-
Luc-eef1a (line 1868 from Leiden Malaria Research Group, the Netherlands). We used P. berghei (ANKA) mCherry-hsp70-Luc-
eef1a when infecting blood cell-specific GOF Piezo1 mice because one of the Cre driver (EpoR-cre) has EGFP expression in
RBCs so that P. berghei (ANKA) GFPcon 259cl2 cannot be used. Blood was collected by cardiac puncture from infected donors
when the parasitemia reached 4%–6% (see below). Parasitized erythrocytes were washed with sterile saline three times at
1000xg for 3min and diluted to 5x105 infected cells/ml as working solution. 200 mL working solution was intravenously injected
into the experimental mice for analysis. For GFP-fluorescence based parasitemia measurement, 1.5 mL tail blood was collected
from infected mice in 180 mL Dulbecco’s Phosphate Buffer Solution with 2% fetal bovine serum, on 96-well plates. The cytometryCell 173, 443–455.e1–e6, April 5, 2018 e2
was performed on NovoCyte Flow Cytometer system (ACEA Biosciences, San Diego, CA) following manufacturer’s instructions.
Briefly, erythrocytes were selected on size for analysis by gating on forward/side-light scatter. Excitation of erythrocytes was per-
formed with a laser at a wavelength of 488 nm and emission of the green fluorescence, or a wavelength of 587nm and emission
of the mCherry was detected using a filter of 530 nm. By gating the uninfected erythrocytes and the GFP-positive infected erythro-
cytes parasitemia was calculated as the percentage of infected cells.
Blood-brain barrier and experimental cerebral malaria assay
When P. berghei infected displayed either experimental cerebral malaria (including ataxia, convulsion, paralysis and/or coma) or se-
vere anemia (immobility and pale blood color), 2% Evans Blue (Sigma-Aldrich, dissolved in sterile saline) was intravenously injected
into P. berghei infected at 5ml/kg body weight. After 45-60 min, euthanized mice were transcardially perfused with Phosphate Buffer
Solution and 4% paraformaldehyde before brains were dissected. To quantify the Evan blue (EB) contents, the infected brains (n = 5
animals per genotype) were cut into small pieces and incubated in 1ml formamide at room temperature for 36 hours, followed by
measuring the optical density at 620nm by Cytation3 (BioTek, Winooski, VT). The concentration of EB dyes was calculated from a
standard curve with the equation (Y = 0.03263*X + 0.03413, where Y = reading, X = EB concentration). To quantify the brain water
content, the infected mice (n = 5 animals per genotype) were sacrificed and brains were dissected. Brain tissues were weighted (wet
weight), then dehydrated at 56C. The sample was re-weighted 48hr later to obtain a dry weight. The percentage of water was calcu-
lated by: BWC = [(wet weight – dry weight) / wet weight] x 100%. Note there are cases that single brains were cut into half, with each
half was used for both Evans blue and water content calculations.
Scanning Electron Microscope
Samples of mouse blood were added to ice cold buffered saline (10mM NaCl, 155mM KCl, 10mM glucose and 1 mM magnesium
chloride) before being fixed in 2.5% glutaraldehyde in 0.1 M cacodylate buffer on ice. Aliquots of the fixed cells were placed on
12mm coverslips previously coated in polylysine for 30 mins. Following a buffer wash and postfixation in buffered 1% osmium te-
troxide, the samples were extensively washed in distilled water. The samples were dehydrated in graded ethanol series followed
by processing in a critical point drier (Tousimis autosamdri 815). The coverslips were then mounted onto SEM stubs with carbon
tape and sputter coated with Iridium (EMS model 150T S) for subsequent examination and documentation on a Hitachi S-4800
SEM (Hitachi High Technologies America Inc., Pleasanton CA) at 5kV.
For human RBCs, samples were fixed at room temperature with 2.5% glutaraldehyde in 0.1M cacodylate buffer followed by 1%
osmium tetroxide, and washed in water. A 10 ml drop of suspension was loaded on the sample carrier and imaged in a FEI Quanta200
FEG microscope in ESEM mode using the gaseous secondary electron detector. The stage was set-up at 2C, the acceleration
voltage was 15kV and the working distance 10 mm. Water was then progressively removed by cycles of decreasing pressure / in-
jection of water, until reaching equilibrium at the dew point. The minimal final pressure in the chamber was 350 Pa. Pictures were
taken with a dwell time of 6 msec.
Osmotic fragility test and hematology test
Blood (for both mouse and human) was diluted at 1:8 into isotonic saline (0.9% NaCl) containing 2 mM HEPES, pH 7.4. 10 mL of the
diluted blood was pipetted into each well (in a row) on a 96-well round-bottom plate. Separate rows were used for separate samples.
225 mL tonicity solutions made from saline solutions at concentration of 0, 20, 25, 30, 35, 40, 45, 50, 55, 60, 80, and 100%. The plate
was incubated for 5min at room temperature followed by 5 min centrifuge at 1000xg. 150 mL supernatant was transferred to 96-well
flat bottom plate for absorbance reading at 540nm using Cytation3 (BioTek,Winooski, VT). The data was analyzed using 4-parameter
sigmoidal nonlinear regression. Hematological properties from mice were analyzed by hematology analyzer at Ruggeri lab, Depart-
ment of Molecular and Experimental Medicine, The Scripps Research Institute, La Jolla, USA)
Gain-of-function Piezo1 mice generation
The targeting strategy was based on the NCBI transcript NM_001037298.1. Wild-type exons 45-51, including the complete 3’ un-
translated region (UTR) were flanked by loxP sites. An additional polyadenylation signal (nucleotide sequence of the synthetic polyA:
gagctccctggcgaattcggtaccaataaaagagctttattttcatgatctgtgtgttggtttttgtgtgcggcgcg) was inserted between the 30 UTR and the
distal loxP site in order to prevent downstream transcription of the mutated exon 51 in the conditional allele. The size of the loxP-
flanked region is 2.8 kb. The exons 45-51, including the splice acceptor site of intron 44 were duplicated and inserted downstream
of the distal loxP site. The R2482H mutation was introduced into the duplicated exon 51. Positive selection markers were flanked by
FRT (Neomycin resistance - NeoR) and F3 (Puromycin resistance- PuroR) sites and inserted into intron 44 and downstream of the
synthetic polyA, respectively. The targeting vector was generated using BAC clones from the C57BL/6J RPCIB-731 BAC library
and transfected into the TaconicArtemis C57BL/6N Tac ES cell line (Taconic, Hudson, NY). Homologous recombinant clones
were isolated using double positive (NeoR and PuroR) selection. The conditional knock-in allele was obtained after Flp-mediated
removal of the selection markers. The constitutive knock-in allele was obtained after Cre-mediated deletion of wild-type exons
45-51 and the synthetic polyA sequencese3 Cell 173, 443–455.e1–e6, April 5, 2018
Mechanical stimulation
For whole-cell recordings, mechanical stimulation was achieved using a fire-polished glass pipette (tip diameter 3–4 mm) positioned
at an angle of 80 to the recorded cells. Downwardmovement of the probe toward the cell was driven by a Clampex controlled piezo-
electric crystal microstage (E625 LVPZT Controller/Amplifier; PhysikInstrumente). The probe had a velocity of 1 mm.ms1 during the
ramp segment of the command for forwardmotion and the stimuluswas applied for 150ms. To assess themechanical responses of a
cell, the probe was first placed as close to the cell as possible (this distance could vary from cell to cell). Then, a series of mechanical
steps in 1 mm increments was applied every 10 s, which allowed full recovery of mechanically activated (MA) currents. Threshold was
calculated by subtracting the distance at which the probe first touched the cell surface from the minimal distance at which mechan-
ically activated currents were evoked. Mechanically activated inward currents were recorded at a holding potential of 80 mV. The
inactivation kinetics at a holding potential of 80 mV of traces of currents reaching at least 75% of the maximal amplitude of current
elicited per cell were fitted with mono-exponential equation (or in some case bi-exponential equation for the rapidly-adapting cur-
rents, accordingly to previous reports (Albuisson et al., 2013) and using the fast time constant giving a value of inactivation time
(t) per responsive cell used for analysis. Channel kinetic properties betweenWT andmutant PIEZO1were compared using Student’s
t test.
Cell culture and transient transfection
PIEZO1KO HEK cells were grown in Dulbecco’s modified Eagle’s medium containing 4.5 mg/ml glucose, 10% fetal bovine serum,
1 3 antibiotics/antimycotics. Cells were plated in 6-well plates and transfected using lipofectamines 2000 (Invitrogen by Thermo-
Fisher Scientific, Carlsbad, CA), according to the manufacturer’s instruction. Human PIEZO1 or mouse Piezo1 mutations fused to
IRES-tdTomato was transfected at 1.4 mg per well (6-well plate) for fluorescent imaging plate reader (see below). Tomeasure calcium
signals, ultrasensitive sensor GCaMP6 (Chen et al., 2013) were transfected at 0.6 mg per well (6-well plate). Cells were incubated for
2 days before electrophysiology experiments or fluorescent imaging plate reader.
Fluorescent imaging plate reader (384-well format)
After transfection, the cells were dissociated from 6-well plates and re-seeded into 384-well plate, at 12,000 cells per well. The plate
was incubated for 2 days thenwashedwith assay buffer (13HBSS, 10mMHEPES, pH7.4) using a ELx405CWplate washer (BioTek,
Winooski, VT). Fluorescence wasmonitored on a fluorescent imaging plate reader (FLIPR) Tetra. A 10-mM stock solution of Yoda1 in
dimethyl sulfoxide (DMSO) was used resulting in a maximum of 1% DMSO in the assay. 10 mM Yoda1 was used in initial screens for
searching gain-of-function mutations (compared to wild-type). Positive hits were then validated by using a series of Yoda1 concen-
trations. Concentration-response curves were fitted using a sigmoidal dose–response at variable slope (GraphPad Prism, La
Jolla, CA).
Real time quantitative PCR.
Total RNA was isolated from mouse whole blood by Quick-RNA Whole Blood (Zymo Research, Irvine, CA). 500 ng total RNA was
used to generate 1st strand cDNA using the Quantitect reverse
transcription kit (QIAGEN). Real time PCR assays were set up using GoTaq qPCRMaster Mix (Promega, MadisonWI). The reaction
was run in the ABI 7900HT fast real time system using 1 ml of the cDNA in a 20 ml reaction according to themanufacturer’s instructions
in triplicates. Primers were designed for target gene (mPiezo1) and reference gene (Gapdh). See Key Resources Table for primer in-
formation. Calibrations and normalizations were done using the 2-DDCT method, where DDCT = ((CT(target gene) -CT (reference
gene)) - (CT (calibrator) - CT (reference gene)).
CD4+ and CD8+ T cell isolation
MoJoSort Mouse CD4 and CD8 Nanobeads kits (BioLegend, San Diego, CA) were used for magnet-based cell separation of CD4/8+
T cells. We performed the procedures based on instructions provided by the kit manual.
Population genetic analysis
Weobtainedminor allele and genotype frequencies from the Exome Aggregation Consortium (ExAC) and the 1000Genomes Project.
2504 genomes were analyzed, 661 from African and 1843 from non-African ancestries. Wright’s fixation index (FST), a measure of
population differentiation, was calculated as follows:
FST =
s2s
p ð1 pÞwhere p is the mean allele frequency and s2 is the allele frequencs y variance between the populations. The 1000 Genomes browser
(http://phase3browser.1000genomes.org/index.html) was used to determine that no alleles were in linkage disequilibrium with
E756del (estimated r2 values were < 0.05). Hardy-Weinberg equilibrium was estimated using the classical binomial expansion to
determine the expected genotype frequencies and x2 tests.Cell 173, 443–455.e1–e6, April 5, 2018 e4
PIEZO1 sequences were obtained from the following sources: modern humans (Homo sapiens, GenBank NG_042229.1), Nean-
derthals (Homo neanderthalensis, Neanderthal Ensembl ENSG00000103335), and Denisovans (Homo sapiens ssp. Denisova, previ-
ously generated reads (Meyer et al., 2012; Reich et al., 2010) aligning to humans [GRCh37/hg19] using the UCSC Genome Browser,
(Kent et al., 2002)). All non-human primate amino acid sequences were obtained from GenBank. The sequences were aligned in
Geneious using MAFFT (Katoh et al., 2002).
Genotyping in African American blood donors
Genotyping E756del carriers by sequencing
25 whole blood samples (5-10ml) were collected fromNormal Blood Donor Service (The Scripps Research Institute, La Jolla, CA) and
Biological Specialty Corporation (Colmar, PA), approved by institutional regulations. 200ul of whole blood samples were used for
genomic DNA isolation by QIAamp DNA Blood Mini Kit (QIAGEN, Germany). A 200bp PCR amplicon that contained E756 locus
was generated for sequencing E756del or wild-type allele (forward primer: 50CAGGCAGGATGCAGTGAGTG30, reverse primer:
50GGACATGGCACAGCAGACTG30. Reverse primer was used for sequencing).
Screening for hemoglobin mutations by sequencing
PCR amplicons that contained potential sickle cell mutation sites were generated (Figure S5). Forward primers: 50AGAA
GAGCCAAGGACAGGTA30; reverse primers: 50TTGCAGCCTCACCTTCTTTC30. Reverse primer was used for sequencing.
Screening for a-thalassemia by multiplex PCR
Each 50 mL reaction contained 20 mmol/L Tris-HCl pH 8.4, 50 mmol/L KCl, 1.5 mmol/L MgCl2, 1 mol/L betaine (SIGMA, St. Louis,
MO), 0.2 mL of each primer (see below) 0.2mmol/L of each dNTP, 2.5 units of polymerase, and 50-100 ng of genomic DNA. Reactions
were carried out on a thermal cycler, with an initial 5-minute denaturation at 95C, 30 cycles of 97C for 45 s, 60C for 1 minute 15 s,
72C for 2 minutes 30 s, and a final extension at 72C for 5 minutes.
Primers:
a2/3.7-F CCCCTCGCCAAGTCCACCC, 3.7/20.5-R AAAGCACTCTAGGGTCCAGCG, a2-R AGACCAGGAAGGGCCGGTG, 4.2-F
GGTTTACCCATGTGGTGCCTC, 4.2-R CCCGTTGGATCTTCTCATTTCCC, SEA-F CGATCTGGGCTCTGTGTTCTC, SEA-R AGCCC
ACGTTGTGTTCATGGC, FIL-F TGCAAATATGTTTCTCTCATTCTGTG, FIL-R ATAACCTTTATCTGCCACATGTAGC, 20.5-F GCCC
AACATCCGGAGTACATG, MED-F TACCCTTTGCAAGCACACGTAC, and MED-R TCAATCTCCGACAGCTCCGAC
P. falciparum culture
P. falciparum Dd2 strain parasites were cultured under standard conditions (Trager and Jensen, 1976), using RPMI media supple-
mented with 0.05 mg/ml gentamycin, 0.014 mg/ml hypoxanthine (prepared fresh), 38.4 mM HEPES, 0.2% Sodium Bicarbonate,
3.4 mM Sodium Hydroxide, 0.05% O+ Human Serum (Denatured at 56C for 40 min; Interstate Blood Bank, Memphis, TN) and
0.0025% Albumax). Human O+ whole blood was obtained from TSRI Normal blood donor service (La Jolla, CA). Leukocyte-free
erythrocytes are stored at 50% hematocrit in RPMI-1640 screening media (as above, but without O+ human serum and with 2x
albumax concentration) at 4C for one to three weeks before experimental use. Cultures were monitored every one to two days
via Giemsa-stained thin smears.
Parasitemia Determination
Asynchronous P. falciparum parasites (Dd2 strain) were cultured in standard conditions (as described above), then synchronized
twice via sorbitol (Lambros and Vanderberg, 1979) and grown to 7%parasitemia at the late trophozoite/schizont stage. Patient blood
was obtained from TSRI Normal blood donor service, washed and centrifuged three times (at 800 x g for 5 min at 4C) with RPMI only
and once with complete media (as above) (Elias and Greene, 1979), with any visible buffy coat being removed after each spin. All
blood samples were given a numerical designation and allele status was not determined until after all data collection was completed.
All genotypes were blinded from experimenters. (Basic Malaria Microscopy, 2010)
Parasite growth was determined in two independent ways: absolute parasitemia determination via thin-blood smear after Giemsa
staining, and inferred parasite growth via the SYBR Green I-based fluorescence assay (Johnson et al., 2007). For the absolute para-
sitemia determination by thin blood smear, parasites were established, starting from the 7% parasitemia cultures above and diluted
using the corresponding patient RBCs, in a 10 mL culture at 5% hematocrit and 0.5% parasitemia (the same as for the Giemsa ab-
solute parasitemia determination assay). Cultures were then grown for 4 days and parasitemia measurements were taken every
2 days. For the SYBR green I inferred parasitemia determination assay, when parasite burden is estimated based upon DNA content,
parasites were cultured in 100 mL volumes in 96-well plates at 5% hematocrit and 0.5%parasitemia with at least 5 replicates per time
point. Parasites were plated on three 96-well black plates with clear bottoms (Fisher Scientific). (One surrogate plate was used for
measurement every two days, with DNA content determined by SYBR Green I incorporation of lysed parasites). Relative parasitemia
was determined by fluorescence measurement, background was determined using uninfected RBCs and subtracted, then relative
parasite burdenwas determined via normalization against a knownO+WT blood sample. In both cases all measurements were taken
for all samples, genotypes were then assigned to numbered patient samples, wild-type versus heterozygote samples were averaged
at each time point, and average parasitemia values were compared.e5 Cell 173, 443–455.e1–e6, April 5, 2018
QUANTIFICATION AND STATISTICAL ANALYSIS
Statistical analysis
All of the data are presented as the mean ± SEM or SD and represent at least 3 independent experiments. Statistical analysis, sig-
nificance level and n values are described in the Figure or Figure legends. For mouse experiments n = number of animals and at least
n = 4 were used. For human blood experiment, n = number of individual blood samples. For comparison, we performed two-tailed
Student’s t test, where p < 0.05 is considered statistically significant. For all datasets, we used Prism7 to perform the statistical
analysis.Cell 173, 443–455.e1–e6, April 5, 2018 e6
Supplemental Figures
Figure S1. Piezo1 GOF Mice Characterization, Related to Figure 1
(A) Modified nucleotides in the last exon of piezo1 cDNA from homozygous Piezo1GOF blood (lower). GG to AC change compared to wild-type (upper).
(B) Piezo1 transcript levels in Piezo1GOF blood mice, p > 0.05 (One-way ANOVA test).
(C) Spleens from Piezo1GOF blood mice are significantly larger than wild-type. ****p < 0.0001, Student’s t test, both compared to wild-type (n = 3 for each group).
Data are presented as means ± SEM.
Figure S2. Piezo1GOF blood/KCa3.1/ Mice RBC Phenotype, Related to Figure 3
Piezo1GOF blood/KCa3.1/mice had normal RBC osmotic fragility as wild-type (p > 0.05), which are significantly larger than heterozygousPiezo1GOF blood mice
(****p < 0.0001). Data are presented as means ± SEM.
Figure S3. Piezo1GOF RBC and Piezo1GOF T cells Mice Characterization, Related to Figure 4
(A) Piezo1GOF RBC mice had RBC dehydration, similar to Piezo1GOF blood (***p < 0.001 and ****p < 0.0001 compared to wild-type, Student t test), while
Piezo1GOF T cells had normal RBC osmotic fragility (p > 0.05 compared to wild-type, Student t test).
(B) cDNA showed that CD4+ and CD8+ T cells expressed Piezo1mRNA with gain-of-function mutation (AC in red square) in homozygous Piezo1GOF T cells mice
(lower panel), whereas wild-type and homozygous Piezo1GOF RBC mice expressed wild-type (GG in red square) mRNA (upper and middle panels). Data are
presented as means ± SEM.
Figure S4. Comparative Genomics, Related to Figure 6
E756del locus in non-human primates, pre-modern humans, and modern humans.
(A) An amino acid alignment of human and non-human primate PIEZO1 sequences (partial). Highlighted amino acids indicate consensus among all sequences
and dashes indicate gaps.
(B) Sequences of individual Neanderthal and Denisovan reads (see STARMethods) were aligned to human chromosome 16. Shown is the region near the E756del
locus in PIEZO1.
(legend on next page)
Figure S5. Genotypes of African American Blood Donors, Related to Figure 7
(A) Screening for E756del in 25 donors. Upper panel: sequence of a200bp PCRamplicon that contains E756 locus in control donors showed 7 repeats of CTC (in
squared brackets). Middle panel: E756del heterozygous carriers showed an ambiguous base at the 7th CTC repeat (in squared brackets). Lower panel: indi-
vidually cloned PCR amplicon from carriers showed the presence of E756del.
(B) Hbb (b-globin) gene from 25 donors showed normal sequence, excluding HbC, HbS (first brackets) and HbE (second brackets).
(C) All 25 donors had normal PCR production (1.9kb band) for a-globin gene in a multiplex PCR screening protocol.
